Abstract:Objective To evaluate the differential diagnostic value of MSCT angiography in hepatic focal nodular hyperplasia(FNH), hepatocellular carcinoma(HCC) and hepatic hemangiomas(HA).Methods The clinical data of patients with liver tumor who underwent MSCT angiography in Peking University Shenzhen Hospital from March 2008 to March 2014 were analyzed retrospectively, including 19 patients with FNH,19 patients with HCC and 17 patients with HA. MSCT angiography was used in three-dimensional reconstruction of tumor vessels. The image characteristics of tumors, such as tumor feeding arteries, arteriovenous fistula, portal vein tumor emboli, draining vein, feeding arteries into the center of the low density, low density separator film, and pseudocapsule, were observed and analyzed statistically by chi-square test.Results Feeding artery thickening was found in all of the patients with FNH, HCC and HA. The display rate were 95.2%(20/21),100.0%(21/21),and 77.3%(17/22), respectively. There were no statistical differences among the three groups (all P values>0.05). Except for feeding artery thickening, pseudocapsule, portal vein tumor emboli and arteriovenous fistula were found in patients with FNH and HCC but not in patients with HA, especially pseudocapsule which was higher than those in patients with FNH (66.7%, 14/21) and HCC(71.4%, 15/21). So the emergence of pseudocapsule could exclude HA, which could differentiate HA from FNH and HCC. Draining vein,feeding arteries into the center of the low density and low density separator film in patients with FNH were 61.9%(13/21), 38.1%(8/21), and 61.9%(13/21), respectively, which were significantly higher than those in patients with HCC[9.5%(2/21), 0(0/21), 0(0/21)], there were statistically differences(χ2=12.548, 7.560, 18.828, all P values<0.05). Portal vein tumor emboli and arteriovenous fistula were not found in patients with FNH but found in patients with HCC[(19.0%,4/21), (28.6%,6/21)] , especially the emergence of portal vein tumor emboli supported HCC diagnosis, which could differentiate HCC from FNH.Conclusions MSCT angiography has great values in the differential diagnosis and important clinical significance for FNH, HCC and HA. It can help guide surgeons to choose the best way of treatment.
汪春荣,沈比先,刘远健,谭四平,贾飞鸽,彭珂文,高德宏,钟文新. 多层螺旋CT血管成像对肝脏局灶性结节增生、原发性肝细胞癌及肝血管瘤的鉴别诊断价值[J]. 中华解剖与临床杂志, 2016, 21(1): 12-17.
Wang Chunrong, Shen Bixian, Liu Yuanjian, Tan Siping, Jia Feige, Peng Kewen, Gao Dehong, Zhong Wenxin. Differential value of multislice CT angiography in hepatic focal nodular hyperplasia, hepatocellular carcinoma and liver hemangioma. Chinese Journal of Anatomy and Clinics, 2016, 21(1): 12-17.
Kamel IR, Liapi E, Fishman EK. Focal nodular hyperplasia: lesion evaluation using 16-MDCT and 3D CT angiography[J]. AJR Am J Roentgenol, 2006, 186(6): 1587-1596. DOI:10.2214/AJR.05.0030
Kitajima K, Maeda T, Ohno Y, et al. Capability of abdominal 320-detector row CT for small vasculature assessment compared with that of 64-detector row CT[J]. Eur J Radiol, 2011, 80(2): 219-223. DOI:10.1016/j.ejrad.2010.05.014
Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia[J]. Ultrasound Med Biol, 2004, 30(9): 1089-1097. DOI:10.1016/j.ultrasmedbio.2004.08.004
Seshadri RM, Besur S, Niemeyer DJ, et al. Survival analysis of patients with stage Ⅰ and Ⅱ hepatocellular carcinoma after aliver transplantation or liver resection[J]. HPB (Oxford), 2014, 16(12): 1102-1109. DOI:10.1111/hpb.12300
[9]
Hoekstra LT, Bieze M, Erdogan D, et al. Management of giant liver hemangiomas: an update[J]. Expert Rev Gastroenterol Hepatol, 2013, 7(3): 263-268. DOI:10.1586/egh.13.10
[10]
Yedibela S, Alibek S, Müller V, et al. Management of hemangioma of the liver: surgical therapy or observation?[J]. World J Surg, 2013, 37(6): 1303-1312. DOI:10.1007/s00268-013-1904-1
Sugimoto K, Moriyasu F, Saito K, et al. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US[J]. Liver Int, 2013, 33(4): 605-615. DOI:10.1111/liv.12098
Willems PW, Taeshineetanakul P, Schenk B, et al. The use of 4D-CTA in the diagnostic work-up of brain arteriovenous malformations[J]. Neuroradiology, 2012, 54(2): 123-131. DOI:10.1007/s00234-011-0864-0
[20]
Lin MC, Tsay PK, Ko SF, et al. Triphasic dynamic CT findings of 63 hepatic focal nodular hyperplasia in 46 patients: correlation with size and pathological findings[J]. Abdom Imaging, 2008, 33(3): 301-307. DOI:10.1007/s00261-007-9258-5
Wang W, Chen LD, Lu MD, et al. Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT[J]. Eur Radiol, 2013, 23(9): 2546-2554. DOI:10.1007/s00330-013-2849-3
Liu QY, Zhang WD, Lai DM, et al. Hepatic focal nodular hyperplasia in children: imaging features on multi-slice computed tomography[J]. World J Gastroenterol, 2012, 18(47): 7048-7055. DOI:10.3748/wjg.v18.i47.7048